Research & Development
Obsidian Therapeutics advances Agni-01 study with first patient enrolled in registration-enabling cohort
5 August 2026 - Clinical-stage biopharmaceutical company Obsidian Therapeutics Inc (Nasdaq:OBX) on Wednesday announced enrolment of the first patient in the registration-enabling cohort of its Phase 1...
CVS Health expands GLP-1 weight management access through integrated care offering
5 August 2026 - Health solutions company CVS Health (NYSE: CVS) announced on Wednesday that it has enhanced its weight management programme to improve access, affordability and support for eligible pa...
Adyen to provide LillyDirect with payment technology services
5 August 2026 - Financial technology platform Adyen announced on Tuesday that it will help facilitate payment services for prescribed patients accessing Eli Lilly and Company's (NYSE:LLY) FDA-app...
Sanofi's MenQuadfi receives EU approval for infants from six weeks
4 August 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Tuesday that it has received European Commission approval to expand the EU indication for MenQuadfi...
Acurx receives FDA guidance supporting ibezapolstat Phase 3 development strategy
3 August 2026 - Biopharmaceutical company Acurx Pharmaceuticals Inc (NASDAQ: ACXP) reported on Monday that it has received further FDA guidance on its ibezapolstat clinical development programme, incl...
Zai Lab's zoci receives FDA orphan designation for neuroendocrine carcinomas
3 August 2026 - Zai Lab Limited (NASDAQ:ZLAB) (HKEX:9688), a research-based, commercial-stage biopharmaceutical company based in China and the United States, announced on Monday that the US Food and D...